Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Endocrinology|January 26, 2026
Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkersLingdong Meng, Zhen Li, Ling Xu, et al.
Frontiers in Endocrinology|October 7, 2022
Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicineZhijia Zhou, Jinghao Zhang, Liping You, et al.
Peerj|March 22, 2024
Integrating single-cell and bulk sequencing data to identify glycosylation-based genes in non-alcoholic fatty liver disease-associated hepatocellular carcinomaZhijia Zhou, Yanan Gao, Longxin Deng, et al.
Frontiers in Immunology|June 15, 2026
Reframing precision nutrition in irritable bowel syndrome: a mechanism-informed conceptual framework for responder prediction and clinical translationYa Zhou, Zhen Li, Yuzhou Chu, et al.
Scientific Reports|November 16, 2024
Bidirectional Mendelian randomization links gut microbiota to primary biliary cholangitisZhijia Zhou, Wenxuan Li, Yuelan Wu, et al.
Frontiers in Genetics|September 9, 2022
Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validationTao Wang, Zhijia Zhou, Xuan Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 15, 2024
An herbal formula Shenlian decoction upregulates M1/M2 macrophage proportion in hepatocellular carcinoma by suppressing complement cascadeWenxuan Li, Liping You, Jiacheng Lin, et al.
Journal of Ethnopharmacology|April 8, 2024
Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathwaysLiping You, Tao Wang, Wenxuan Li, et al.
Biomed Research International|April 16, 2021
The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver DiseaseZhijia Zhou, Penghua Lai, Shaoliang Zhang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 25, 2025
Huangjia Ruangan granules with entecavir for fibrosis regression in Chroinc Hepatitis B: A multicenter, randomized, double-blind, phase II trialXiaojun Zhu, Jinghao Zhang, Zhijia Zhou, et al.
Pageof 1